Vamsi Bollu

Vamsi Bollu

Sunovion Pharmaceuticals - / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4973643
person_outline Vamsi Bollu's MOST POPULAR ARTICLES
1-) Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients EQ Wu, S Johnson, N Beaulieu, M Arana, V Bollu, A Guo, J Coombs, ... Current medical research and opinion 26 (1), 61-69, 2010 1562010
2-) Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemiaEQ Wu, A Guerin, AP Yu, VK Bollu, A Guo, JD GriffinCurrent medical research and opinion 26 (12), 2861-2869, 2010792010
3-) Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trialsJE Signorovitch, EQ Wu, KA Betts, K Parikh, E Kantor, A Guo, VK Bollu, ...Current medical research and opinion 27 (6), 1263-1271, 2011782011
4-) Epidemiology, survival, and costs of localized gastrointestinal stromal tumorsJL Rubin, M Sanon, DCA Taylor, J Coombs, V Bollu, L SirulnikInternational journal of general medicine, 121-130, 2011762011
5-) Predictors of treatment non-adherence in patients treated with imatinib mesylate for chronic myeloid leukemia.M StCharles, VK Bollu, E Hornyak, J Coombs, CM Blanchette, ...Blood 114 (22), 2209, 2009622009